What Life Sciences Companies Get Wrong When Building Cross-Border R&D Structures
These structures, if not set up and managed correctly from day one, can create significant accounting, tax and compliance headaches down the road.
These structures, if not set up and managed correctly from day one, can create significant accounting, tax and compliance headaches down the road.
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.
A good outsourced partner can work alongside in-house accountants and stay on top of the moving target of healthcare accounting regulations, addressing tax risks and identifying cost-saving opportunities.
Mylan evidently subscribes to a "living in the gray" mentality when it comes to business operations.